The estimated Net Worth of Glenn David is at least $18.7 Milion dollars as of 23 February 2022. Mr. David owns over 32,390 units of Zoetis Inc stock worth over $15,001,990 and over the last 10 years he sold ZTS stock worth over $0. In addition, he makes $3,672,350 as Chief Financial Officer a Executive Vice President at Zoetis Inc.
Glenn has made over 11 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 32,390 units of ZTS stock worth $2,515,084 on 23 February 2022.
The largest trade he's ever made was exercising 43,778 units of Zoetis Inc stock on 5 March 2020 worth over $2,355,256. On average, Glenn trades about 3,618 units every 21 days since 2014. As of 23 February 2022 he still owns at least 78,962 units of Zoetis Inc stock.
You can see the complete history of Mr. David stock trades at the bottom of the page.
Glenn C. David serves as Chief Financial Officer, Executive Vice President of the Company. Mr. David has served as our Executive Vice President and Chief Financial Officer since August 2016. With more than 25 years of experience in finance and operations, Mr. David has played a key role in leading the financial operations for Zoetis since its initial public offering in 2013. He served as our Senior Vice President of Finance Operations from 2013 to 2016 and as acting Chief Financial Officer from April 2014 through August 2014. Mr. David joined Pfizer in 1999 and held various financial roles, including Vice President of Global Finance for Pfizer Animal Health, our predecessor company, and Vice President of Finance for the U.S. Primary Care franchise.
As the Chief Financial Officer a Executive Vice President of Zoetis Inc, the total compensation of Glenn David at Zoetis Inc is $3,672,350. There are no executives at Zoetis Inc getting paid more.
Glenn David is 48, he's been the Chief Financial Officer a Executive Vice President of Zoetis Inc since 2016. There are 21 older and 1 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
Glenn's mailing address filed with the SEC is 300 FRANK W. BURR BLVD.,, STE 21, TEANECK, NJ, 07666.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio a Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: